Measles virus induction of human endothelial cell tissue factor procoagulant activity in vitro.
Measles virus infection of microvascular endothelium in vivo and ensuing endothelial cell activation may be important in the pathogenesis of subsequent inflammation in target organs. This study investigated the capacity of measles virus to induce procoagulant activity, in vitro, in endothelial cells isolated from human umbilical cord veins. Endothelial cells were infected with a clinical isolate of measles virus propagated in Vero cells. Cells were also incubated with bacterial lipopolysaccharide (10 micrograms/ml), herpes simplex virus type 1, cytomegalovirus or culture medium alone as positive and negative controls, respectively. Endothelial cell procoagulant activity was measured in a one-stage clotting assay. Measles virus stimulated both a time and dose-dependent endothelial cell procoagulant response by the induction of tissue factor synthesis, confirmed by both immunocytochemistry and its dependence on factor VII for activity. This activity was reduced by u.v.-irradiation of the virus. Infected cells were analysed by double immunofluorescent staining for both tissue factor and measles virus N-protein, and examined using confocal scanning laser microscopy. Cells expressing tissue factor were also positive for the measles virus N-protein. Low levels of interleukin-1 were detected in some viral inocula derived from measles virus-infected Vero cells, however neutralising antibody to interleukin-1 failed to inhibit the endothelial cell procoagulant response to measles virus, whereas it significantly reduced procoagulant activity induced in endothelial cells by recombinant interleukin-1. The capacity of measles virus to induce endothelial tissue factor in vitro, may be relevant to the thrombotic vasculopathy associated with measles virus infection in vivo.
Mazure
G
G
Inflammatory Bowel Disease Study Group, Royal Free Hospital School of Medicine, London, U.K.
Grundy
J E
JE
Nygard
G
G
Hudson
M
M
Khan
K
K
Srai
K
K
Dhillon
A P
AP
Pounder
R E
RE
Wakefield
A J
AJ
D000818:Animals; D000906:Antibodies; D002213:Capsid / Q000032:analysis / Q000096:biosynthesis; D002478:Cells, Cultured; D002522:Chlorocebus aethiops; D003587:Cytomegalovirus / Q000502:physiology; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology* / Q000821:virology; D005169:Factor VIII / Q000378:metabolism; D018259:Herpesvirus 1, Human / Q000502:physiology; D006801:Humans; D007150:Immunohistochemistry; D007375:Interleukin-1 / Q000276:immunology / Q000494:pharmacology; D007700:Kinetics; D008070:Lipopolysaccharides / Q000494:pharmacology; D008459:Measles virus / Q000302:isolation & purification / Q000502:physiology* / Q000528:radiation effects; D011994:Recombinant Proteins / Q000494:pharmacology; D013925:Thromboplastin / Q000032:analysis / Q000096:biosynthesis*; D013997:Time Factors; D014466:Ultraviolet Rays; D014471:Umbilical Veins; D014709:Vero Cells; D014758:Viral Core Proteins / Q000032:analysis / Q000096:biosynthesis
D000906:Antibodies; D007375:Interleukin-1; D008070:Lipopolysaccharides; D011994:Recombinant Proteins; D014758:Viral Core Proteins; D005169:Factor VIII; D013925:Thromboplastin